छोड़कर सामग्री पर जाएँ
Singapore’s Grab plans biggest job-cut round since pandemic

Singapore’s Grab plans biggest job-cut round since pandemic

The reductions are set to be announced as soon as this week and are likely to surpass a 2020 round that shrank staff by 5%, or about 360 employees, according to people familiar with the matter.

Read More

​ The reductions are set to be announced as soon as this week and are likely to surpass a 2020 round that shrank staff by 5%, or about 360 employees, according to people familiar with the matter. The reductions are set to be announced as soon as this week and are likely to surpass a 2020 round that shrank staff by 5%, or about 360 employees, according to people familiar with the matter.  Moneycontrol Latest News Read More  

The reductions are set to be announced as soon as this week and are likely to surpass a 2020 round that shrank staff by 5%, or about 360 employees, according to people familiar with the matter.

KIMS gains after 5% equity changes hands, third big block in 4 months

KIMS gains after 5% equity changes hands, third big block in 4 months

KIMS is a chain of 12 multi-specialty hospitals, operating mainly in Telangana, Andhra Pradesh and Maharashtra

Read More

​ KIMS is a chain of 12 multi-specialty hospitals, operating mainly in Telangana, Andhra Pradesh and Maharashtra KIMS is a chain of 12 multi-specialty hospitals, operating mainly in Telangana, Andhra Pradesh and Maharashtra  Moneycontrol Latest News Read More  

KIMS is a chain of 12 multi-specialty hospitals, operating mainly in Telangana, Andhra Pradesh and Maharashtra

JB Chemicals hits record high as Jefferies initiates coverage with #39;buy#39; call

JB Chemicals hits record high as Jefferies initiates coverage with #39;buy#39; call

Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies

Read More

​ Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies  Moneycontrol Latest News Read More  

Jefferies, which sees a 19% upside potential, says JB Chemicals is one of the fastest-growing domestic pharma company with a dominance in cardiac and gastro therapies

Latest gold prices: Below $1950, near three-month low

Latest gold prices: Below $1950, near three-month low

Next, investors will be closely watching US Federal Reserve Chair Powell#39;s testimony before Congress on Wednesday, as it may provide insights into the central bank#39;s monetary policy stance. Additionally, there is anticipation of a potential rate hike by the Bank of England (BoE) on Thursday.

Read More

​ Next, investors will be closely watching US Federal Reserve Chair Powell#39;s testimony before Congress on Wednesday, as it may provide insights into the central bank#39;s monetary policy stance. Additionally, there is anticipation of a potential rate hike by the Bank of England (BoE) on Thursday. Next, investors will be closely watching US Federal Reserve Chair Powell#39;s testimony before Congress on Wednesday, as it may provide insights into the central bank#39;s monetary policy stance. Additionally, there is anticipation of a potential rate hike by the Bank of England (BoE) on Thursday.  Moneycontrol Latest News Read More  

Next, investors will be closely watching US Federal Reserve Chair Powell#39;s testimony before Congress on Wednesday, as it may provide insights into the central bank#39;s monetary policy stance. Additionally, there is anticipation of a potential rate hike by the Bank of England (BoE) on Thursday.

Carlos Ghosn sues Nissan for $1 billion in damages over ouster

Carlos Ghosn sues Nissan for $1 billion in damages over ouster

The former auto executive, who forged Nissan’s carmaking alliance with Renault SA and Mitsubishi Motors Corp., filed his claims with the public prosecutor in the Court of Cassation in Lebanon, where he has lived since his dramatic escape from Japan in late 2019 to flee trial.

Read More

​ The former auto executive, who forged Nissan’s carmaking alliance with Renault SA and Mitsubishi Motors Corp., filed his claims with the public prosecutor in the Court of Cassation in Lebanon, where he has lived since his dramatic escape from Japan in late 2019 to flee trial. The former auto executive, who forged Nissan’s carmaking alliance with Renault SA and Mitsubishi Motors Corp., filed his claims with the public prosecutor in the Court of Cassation in Lebanon, where he has lived since his dramatic escape from Japan in late 2019 to flee trial.  Moneycontrol Latest News Read More  

The former auto executive, who forged Nissan’s carmaking alliance with Renault SA and Mitsubishi Motors Corp., filed his claims with the public prosecutor in the Court of Cassation in Lebanon, where he has lived since his dramatic escape from Japan in late 2019 to flee trial.

Road award dip in April-May will not impact long term goals, bullish on Infrastructure sector; say analysts

Road award dip in April-May will not impact long term goals, bullish on Infrastructure sector; say analysts

The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions.

Read More

​ The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions. The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions.  Moneycontrol Latest News Read More  

The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions.

Road award dip in April-May will not impact long term goals, bullish on Infrastructure sector; say analysts

Road award dip in April-May will not impact long term goals, bullish on Infrastructure sector; say analysts

The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions.

Read More

​ The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions. The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions.  Moneycontrol Latest News Read More  

The total road awarding was hardly around 100 kilometers in April and May. Nonetheless, Axis Securities remains optimistic on the long-term prospects of PNC Infratech, HG Infra Engineering Limited, and KNR Constructions.

ITI shares gain 3% on RD initiative contract with C-DOT and TCIL

ITI shares gain 3% on RD initiative contract with C-DOT and TCIL

ITI Limited stock has given a return of 5.12 percent since the start of this year. Thus, outperforming the benchmark Nifty50 index which has given a return 2.24 percent over the same duration.

Read More

​ ITI Limited stock has given a return of 5.12 percent since the start of this year. Thus, outperforming the benchmark Nifty50 index which has given a return 2.24 percent over the same duration. ITI Limited stock has given a return of 5.12 percent since the start of this year. Thus, outperforming the benchmark Nifty50 index which has given a return 2.24 percent over the same duration.  Moneycontrol Latest News Read More  

ITI Limited stock has given a return of 5.12 percent since the start of this year. Thus, outperforming the benchmark Nifty50 index which has given a return 2.24 percent over the same duration.

Buy Dalmia Bharat; target of Rs 2550: Motilal Oswal

Buy Dalmia Bharat; target of Rs 2550: Motilal Oswal

Motilal Oswal is bullish on Dalmia Bharat recommended buy rating on the stock with a target price of Rs 2550 in its research report dated June 19, 2023.

Read More

​ Motilal Oswal is bullish on Dalmia Bharat recommended buy rating on the stock with a target price of Rs 2550 in its research report dated June 19, 2023. Motilal Oswal is bullish on Dalmia Bharat recommended buy rating on the stock with a target price of Rs 2550 in its research report dated June 19, 2023.  Moneycontrol Latest News Read More  

Motilal Oswal is bullish on Dalmia Bharat recommended buy rating on the stock with a target price of Rs 2550 in its research report dated June 19, 2023.

Renewed bull run underway, NBFCs and Home Improvement sectors good bets: Stellar Wealth’s Gautam Baid

Renewed bull run underway, NBFCs and Home Improvement sectors good bets: Stellar Wealth’s Gautam Baid

Stellar Wealth’s Gautam Baid advices investors to opt for a bottom-up approach while investing while keeping an eye out for market tailwinds.

Read More

​ Stellar Wealth’s Gautam Baid advices investors to opt for a bottom-up approach while investing while keeping an eye out for market tailwinds. Stellar Wealth’s Gautam Baid advices investors to opt for a bottom-up approach while investing while keeping an eye out for market tailwinds.  Moneycontrol Latest News Read More  

Stellar Wealth’s Gautam Baid advices investors to opt for a bottom-up approach while investing while keeping an eye out for market tailwinds.

hi_INहिन्दी